Although it is classified as a blood thinner/Factor Xa inhibitor, the anti-coagulant drug XARELTO® has been approved by the U.S. Food and Drug Administration (FDA) for another use. A recent report shows that it can be taken to reduce the risks of peripheral artery disease (PAD), chronic coronary disease (CAD), strokes, other cardiovascular events, and » Read More
There is room for human error in everything that we do. Despite the years of training that doctors endure, they, too, experience the reality of what it means to be human. And though they work long hours, they cannot be everywhere. For patients far away, and to help minimize the risk of human error, physicians » Read More